Anti-pseudomonas activity of azlocillin during pulmonary infection in patients with cystic fibrosis.
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001390:Azlocillin; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications*; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy*; D008297:Male; D010406:Penicillins / Q000378:metabolism / Q000494:pharmacology*; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D013183:Sputum / Q000032:analysis
D000900:Anti-Bacterial Agents; D010406:Penicillins; D001390:Azlocillin